It's still in stock, distributors say
October 17, 2008 (published)
Veterinarians are reporting a glycopyrrolate shortage, but of the three
distributors contacted by the VIN News Service, just one reports a
Internet rumors have circulated of a raw materials shortage in
relationship to the drug, but IVX Animal Health, believed by some to be
the only maker of the drug currently used in veterinary medicine,
claimed that they do not currently manufacture glycopyrrolate, despite
submitting a Food and Drug Administration (FDA) NADA application to
make generic glycopyrrolate in 2006. Instead, IVX Animal Health
representatives referred to Fort Dodge Animal Health's status as
the only manufacturer of glycopyrrolate approved by the agency for use in animals.
Yet a call to Fort Dodge reveals the company stopped manufacturing
ROBINUL-V, the only brand-name version of glycopyrrolate in veterinary
medicine, in August 2007. Officials did not give a reason for the
Despite the confusion, veterinarians still have access to the
human-version of the drug, according to Webster Veterinary
Supply Inc. and Butler Animal Health Supply. However, Midwest Veterinary Supply reports a
"All I can tell you is that we have it in stock, and we're not set
to get another order in until November," says Dr. Scott Handler,
Webster's director of Marketing, Communication and Education.
VIN News Service commentaries are opinion pieces presenting insights, personal experiences and/or perspectives on topical issues by members of the veterinary community. To submit a commentary for consideration, email firstname.lastname@example.org.
Information and opinions expressed in letters to the editor are those of the author and are independent of the VIN News Service. Letters may be edited for style. We do not verify their content for accuracy.